Reference to what was published in the news under “Avigan® Approved for COVID-19 Treatment in Malaysia”, Agility would like to announce that the Malaysian Ministry of Health’s Drug Control Authority has approved Avigan® for use in treatment of COVID-19 patients.
Earlier this year, Global Response Aid (GRA), an affiliate of Agility, and Dr. Reddy’s Laboratories signed an agreement for exclusive global production, distribution and commercialization of the drug with its developer, FujiFilm Toyama Chemical.
Agility cannot assess the financial impact at the moment.
Get real-time air & ocean freight quotes and access to a powerful dashboard.
Kuwait-based Agility Logistics Parks customers can log-on to view contracts and make payments.
UK MOD personnel can log-in to the GRMS portal to schedule household relocation shipments.
Get real-time air & ocean freight quotes and access to a powerful dashboard.
Kuwait-based Agility Logistics Parks customers can log-on to view contracts and make payments.
UK MOD personnel can log-in to the GRMS portal to schedule household relocation shipments.
Agility Reports FY 2023 Net Profit of KD 83.6 Million and recommends a 10 fils per share as dividends
Learn More
Download Report
* Featured companies from Agility’s wider portfolio; not full list.
Get real-time air & ocean freight quotes and access to a powerful dashboard.
Kuwait-based Agility Logistics Parks customers can log-on to view contracts and make payments.
UK MOD personnel can log-in to the GRMS portal to schedule household relocation shipments.
Get real-time air & ocean freight quotes and access to a powerful dashboard.
Kuwait-based Agility Logistics Parks customers can log-on to view contracts and make payments.
UK MOD personnel can log-in to the GRMS portal to schedule household relocation shipments.
Commenting on published news
Reference to what was published in the news under “Avigan® Approved for COVID-19 Treatment in Malaysia”, Agility would like to announce that the Malaysian Ministry of Health’s Drug Control Authority has approved Avigan® for use in treatment of COVID-19 patients.
Earlier this year, Global Response Aid (GRA), an affiliate of Agility, and Dr. Reddy’s Laboratories signed an agreement for exclusive global production, distribution and commercialization of the drug with its developer, FujiFilm Toyama Chemical.
Agility cannot assess the financial impact at the moment.
Sincerely,
Investor Relations Team
Latest Financial News
April 25, 2024
ADX decision on listing Agility Global PLC
April 21, 2024
Clarification on the news
April 16, 2024
Clarification on Unusual Trade
April 7, 2024
Analyst Conference for the year 2023
April 1, 2024
Agility’s FY 2023 Earnings Webcast
March 31, 2024
Agility’s FY 2023 BOD results